Paper36929083
Pharmacogenomic and Statistical Analysis.
Bai H and 2 others. Methods Mol Biol, 2023. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Pharmacogenomic and Statistical Analysis. Papers, record 36929083. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36929083
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Pharmacogenetics | Major topic |
| Research Design | Major topic |
| Pharmacogenomic Testing | |
| Phenotype |
Source PubMed
References97
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19540002 | Genetic and clinical factors relating to warfarin dosing. | Trends Pharmacol Sci | 2009 | https://conductscience.org/library/papers/19540002 | PubMed |
| 2 | 7831671 | The antiaggregating activity of clopidogrel is due to a metabolic activation by the hepatic cytochrome P450-1A. | Thromb Haemost | 1994 | https://conductscience.org/library/papers/7831671 | PubMed |
| 3 | 33193687 | Pharmacogenetics of Statin-Induced Myotoxicity. | Front Genet | 2020 | https://conductscience.org/library/papers/33193687 | PubMed |
| 4 | 21386754 | Cerivastatin, genetic variants, and the risk of rhabdomyolysis. | Pharmacogenet Genomics | 2011 | https://conductscience.org/library/papers/21386754 | PubMed |
| 5 | 26086347 | ABCG2 gene polymorphisms as risk factors for atorvastatin adverse reactions: a case-control study. | Pharmacogenomics | 2015 | https://conductscience.org/library/papers/26086347 | PubMed |
| 6 | 28297622 | Clinical Trials in the Genomic Era. | J Clin Oncol | 2017 | https://conductscience.org/library/papers/28297622 | PubMed |
| 7 | 5391106 | Steady-state plasma levels of nortriptyline in twins: influence of genetic factors and drug therapy. | Br Med J | 1969 | https://conductscience.org/library/papers/5391106 | PubMed |
| 8 | 17700589 | The star-allele nomenclature: retooling for translational genomics. | Clin Pharmacol Ther | 2007 | https://conductscience.org/library/papers/17700589 | PubMed |
| 9 | 3123997 | Characterization of the common genetic defect in humans deficient in debrisoquine metabolism. | Nature | 1988 | https://conductscience.org/library/papers/3123997 | PubMed |
| 10 | 23300413 | Chapter 11: Genome-wide association studies. | PLoS Comput Biol | 2012 | https://conductscience.org/library/papers/23300413 | PubMed |
| 11 | 22588608 | Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project. | Clin Pharmacol Ther | 2012 | https://conductscience.org/library/papers/22588608 | PubMed |
| 12 | 22739144 | Optimizing drug outcomes through pharmacogenetics: a case for preemptive genotyping. | Clin Pharmacol Ther | 2012 | https://conductscience.org/library/papers/22739144 | PubMed |
| 13 | 21270786 | CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network. | Clin Pharmacol Ther | 2011 | https://conductscience.org/library/papers/21270786 | PubMed |
| 14 | 31562822 | The Clinical Pharmacogenetics Implementation Consortium: 10 Years Later. | Clin Pharmacol Ther | 2020 | https://conductscience.org/library/papers/31562822 | PubMed |
| 15 | 11908751 | Integrating genotype and phenotype information: an overview of the PharmGKB project. Pharmacogenetics Research Network and Knowledge Base. | Pharmacogenomics J | 2001 | https://conductscience.org/library/papers/11908751 | PubMed |
| 16 | 22992668 | Pharmacogenomics knowledge for personalized medicine. | Clin Pharmacol Ther | 2012 | https://conductscience.org/library/papers/22992668 | PubMed |
| 17 | 20150829 | Cytochrome P450 2C9-CYP2C9. | Pharmacogenet Genomics | 2010 | https://conductscience.org/library/papers/20150829 | PubMed |
| 18 | 19898265 | PharmGKB summary: very important pharmacogene information for angiotensin-converting enzyme. | Pharmacogenet Genomics | 2010 | https://conductscience.org/library/papers/19898265 | PubMed |
| 19 | 20154640 | Very important pharmacogene summary: thiopurine S-methyltransferase. | Pharmacogenet Genomics | 2010 | https://conductscience.org/library/papers/20154640 | PubMed |
| 20 | 28442506 | Genome-Wide Association Studies of Chemotherapeutic Toxicities: Genomics of Inequality. | Clin Cancer Res | 2017 | https://conductscience.org/library/papers/28442506 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 41988135 | Multimodal analgesia strategies enhance postoperative recovery and mitigate inflammatory responses in women undergoing elective surgery for endometrial cancer: a retrospective cohort study. | Front Oncol | 2026 | https://conductscience.org/library/papers/41988135 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36929083
GET https://conductscience.org/api/papers/v1/36929083/references?page=2